201 related articles for article (PubMed ID: 29408216)
1. Cervical Cancer Screening: What's New? Updates for the Busy Clinician.
Zhang S; McNamara M; Batur P
Am J Med; 2018 Jun; 131(6):702.e1-702.e5. PubMed ID: 29408216
[TBL] [Abstract][Full Text] [Related]
2. Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices.
Blatt AJ; Kennedy R; Luff RD; Austin RM; Rabin DS
Cancer Cytopathol; 2015 May; 123(5):282-8. PubMed ID: 25864682
[TBL] [Abstract][Full Text] [Related]
3. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
[TBL] [Abstract][Full Text] [Related]
4. Squamous cell carcinoma of the cervix: a cytology-histology-human papillomavirus correlation in clinical practice.
Miller RA; Waters LL; Mody DR; Tams KC
Arch Pathol Lab Med; 2015 Jun; 139(6):776-81. PubMed ID: 26030246
[TBL] [Abstract][Full Text] [Related]
5. Glandular Lesions of the Cervix in Clinical Practice: A Cytology, Histology, and Human Papillomavirus Correlation Study From 2 Institutions.
Miller RA; Mody DR; Tams KC; Thrall MJ
Arch Pathol Lab Med; 2015 Nov; 139(11):1431-6. PubMed ID: 25951104
[TBL] [Abstract][Full Text] [Related]
6. [New guidelines in regard to cervical cancer screening].
Vargas-Hernández VM; Acosta-Altamirano G; Moreno-Eutimio MA; Vargas-Aguilar VM
Cir Cir; 2014; 82(4):453-9. PubMed ID: 25167359
[TBL] [Abstract][Full Text] [Related]
7. Attitudes toward cervical cancer screening among women receiving human papillomavirus vaccination in a university-hospital-based community: interim 2-year follow-up results.
Miyagi E; Sukegawa A; Motoki Y; Kaneko T; Maruyama Y; Asai-Sato M; Numazaki R; Mizushima S; Hirahara F
J Obstet Gynaecol Res; 2014 Apr; 40(4):1105-13. PubMed ID: 24428631
[TBL] [Abstract][Full Text] [Related]
8. Screening test results associated with cancer diagnoses in 287 women with cervical squamous cell carcinoma.
Li Z; Austin RM; Guo M; Zhao C
Arch Pathol Lab Med; 2012 Dec; 136(12):1533-40. PubMed ID: 22900617
[TBL] [Abstract][Full Text] [Related]
9. Muslim immigrant women's views on cervical cancer screening and HPV self-sampling in Ontario, Canada.
Vahabi M; Lofters A
BMC Public Health; 2016 Aug; 16(1):868. PubMed ID: 27557928
[TBL] [Abstract][Full Text] [Related]
10. The combined impact of implementing HPV immunisation and primary HPV screening in New Zealand: Transitional and long-term benefits, costs and resource utilisation implications.
Hall MT; Smith MA; Lew JB; O'Hallahan J; Fentiman G; Neal H; Sage M; Canfell K
Gynecol Oncol; 2019 Mar; 152(3):472-479. PubMed ID: 30876491
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
[TBL] [Abstract][Full Text] [Related]
12. Cervical cancer screening with clinic-based Pap test versus home HPV test among Somali immigrant women in Minnesota: a pilot randomized controlled trial.
Sewali B; Okuyemi KS; Askhir A; Belinson J; Vogel RI; Joseph A; Ghebre RG
Cancer Med; 2015 Apr; 4(4):620-31. PubMed ID: 25653188
[TBL] [Abstract][Full Text] [Related]
13. Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus.
Kim JJ; Burger EA; Sy S; Campos NG
J Natl Cancer Inst; 2017 Feb; 109(2):. PubMed ID: 27754955
[TBL] [Abstract][Full Text] [Related]
14. Impact of pap test compliance and cervical cancer screening intervals on human papillomavirus vaccine acceptance.
Ferris DG; Waller J; Dickinson A; McCracken C; Goebel A
J Low Genit Tract Dis; 2012 Jan; 16(1):39-44. PubMed ID: 22126831
[TBL] [Abstract][Full Text] [Related]
15. Increasing participation in cervical cancer screening: offering a HPV self-test to long-term non-attendees as part of RACOMIP, a Swedish randomized controlled trial.
Broberg G; Gyrd-Hansen D; Miao Jonasson J; Ryd ML; Holtenman M; Milsom I; Strander B
Int J Cancer; 2014 May; 134(9):2223-30. PubMed ID: 24127304
[TBL] [Abstract][Full Text] [Related]
16. Cervical cancer screening, human papillomavirus vaccination practices and current infrastructure in Israel.
Schejter E; Bornstein J; Siegler E
Vaccine; 2013 Nov; 31 Suppl 8():I42-5. PubMed ID: 24229718
[TBL] [Abstract][Full Text] [Related]
17. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
Saraiya M; Berkowitz Z; Yabroff KR; Wideroff L; Kobrin S; Benard V
Arch Intern Med; 2010 Jun; 170(11):977-85. PubMed ID: 20548011
[TBL] [Abstract][Full Text] [Related]
18. Cervical cancer incidence in British Columbia: Predicting effects of changes from Pap to human papillomavirus screening and of changes in screening participation.
Coldman A; van Niekerk D; Smith L; Ogilvie G
J Med Screen; 2017 Dec; 24(4):195-200. PubMed ID: 27810984
[TBL] [Abstract][Full Text] [Related]
19. Prior high-risk HPV testing and Pap test results for 427 invasive cervical cancers in China's largest CAP-certified laboratory.
Zheng B; Li Z; Griffith CC; Yan S; Chen C; Ding X; Liang X; Yang H; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):428-34. PubMed ID: 25954852
[TBL] [Abstract][Full Text] [Related]
20. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]